Social inequalities in access to contraception in France

被引:19
作者
Bajos, N [1 ]
Oustry, P [1 ]
Leridon, H [1 ]
Bouyer, J [1 ]
Job-Spira, N [1 ]
Hassoun, D [1 ]
机构
[1] INSERM, U569, IFR69, F-94276 Le Kremlin Bicetre, France
来源
POPULATION | 2004年 / 59卷 / 3-4期
关键词
D O I
10.2307/3654992
中图分类号
C921 [人口统计学];
学科分类号
摘要
Since contraception was legalized in France in 1967, there has been a sustained increase in use of medical contraception, notably third generation contraceptive pills that are not reimbursed by the social security. This change in contraceptive behaviour may well have generated new forms of inequality. This article shows that social inequalities in contraceptive use in France have changed in recent decades. At the beginning of the 1980s, access to the pill and the intrauterine device (IUD) was characterized by large inequalities. These inequalities subsequently declined sharply, for the pill in the 1990s and for the IUD at the end of the 1990s. COCON data show for the first time that such inequalities now affect access to third generation oral contraceptives. In addition to the financial obstacle of high price. the inequalities in access to these non-refundable products seem to result from women's expectations, which are related to their social class, and from the behaviour of the prescribing doctors, which also varies with the woman's social class. However, women seem not to prefer these new products
引用
收藏
页码:479 / 502
页数:24
相关论文
共 18 条
[11]  
ROSENFELD JA, 1993, J FAM PRACTICE, V36, P169
[12]   Patient satisfaction: A review of issues and concepts [J].
Sitzia, J ;
Wood, N .
SOCIAL SCIENCE & MEDICINE, 1997, 45 (12) :1829-1843
[13]   Myocardial infarction and third generation oral contraceptives: aggregation of recent studies [J].
Spitzer, WO ;
Faith, JM ;
MacRae, KD .
HUMAN REPRODUCTION, 2002, 17 (09) :2307-2314
[14]   A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 μg ethinylestradio1/75 μg gestodene (Meliane) and 30 μg ethinylestradio1/75 μg gestodene (Gynera®) [J].
Taneepanichskul, S ;
Kriengsinyot, R ;
Jaisamrarn, U .
CONTRACEPTION, 2002, 66 (06) :407-409
[15]  
Tonkelaar I, 2001, EUROPEAN J CONTRACEP, V6, P153
[16]   BIRTH-CONTROL AND SOCIAL GROUP - CONTRACEPTION, ACCIDENTAL PREGNANCIES AND ABORTION [J].
TOULEMON, L ;
LERIDON, H .
POPULATION, 1992, 47 (01) :1-46
[17]  
Toulemon L, 1995, Rev Prat, V45, P2395
[18]   PATIENT SATISFACTION - A VALID CONCEPT [J].
WILLIAMS, B .
SOCIAL SCIENCE & MEDICINE, 1994, 38 (04) :509-516